Investing Corcept Therapeutics stock plunges after FDA rejects hypercortisolism drug Dylan D. DavisDecember 31, 2025 Corcept Therapeutics stock plunges after FDA rejects hypercortisolism drug Source link
Union Pacific will be a double-digit earnings story in 2026, Hightower’s Stephanie Link says Stephanie Link, chief investment strategist and portfolio manager at Hightower Advisors, is betting on Union Pacific as a strong play…
S&P revises Ontex Group outlook to stable on weaker cash flow S&P revises Ontex Group outlook to stable on weaker cash flow Source link
Apple loses appeals court ruling in App Store fight with Epic Apple loses appeals court ruling in App Store fight with Epic Source link
